Medicover AB (publ)

OTCPK:MCVE.Y Stock Report

Market Cap: US$2.2b

Medicover Future Growth

Future criteria checks 4/6

Medicover is forecast to grow earnings and revenue by 23.5% and 15.4% per annum respectively. EPS is expected to grow by 16.7% per annum. Return on equity is forecast to be 13.5% in 3 years.

Key information

23.5%

Earnings growth rate

16.7%

EPS growth rate

Healthcare earnings growth21.1%
Revenue growth rate15.4%
Future return on equity13.5%
Analyst coverage

Low

Last updatedn/a

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:MCVE.Y - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20241,91174842343
12/31/20231,65154722054
12/31/20221,49545661924
6/30/20221,4556067195N/A
3/31/20221,4428895205N/A
12/31/20211,377102115217N/A
9/30/20211,29993106203N/A
6/30/20211,2269091176N/A
3/31/20211,07652104176N/A
12/31/20209982683155N/A
9/30/20209301475141N/A
6/30/2020879453122N/A
3/31/20208841631100N/A
12/31/2019844232487N/A
9/30/2019796192879N/A
6/30/2019751193986N/A
3/31/2019709204085N/A
12/31/2018672223374N/A
9/30/2018643283475N/A
6/30/2018620262261N/A
3/31/2018600232055N/A
12/31/2017580192150N/A
9/30/2017560101340N/A
6/30/20175409-536N/A
3/31/20175226-1731N/A
12/31/20164974-2826N/A
12/31/20154168N/A29N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MCVE.Y's forecast earnings growth (23.5% per year) is above the savings rate (1.9%).

Earnings vs Market: MCVE.Y's earnings (23.5% per year) are forecast to grow faster than the US market (14.9% per year).

High Growth Earnings: MCVE.Y's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MCVE.Y's revenue (15.4% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: MCVE.Y's revenue (15.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MCVE.Y's Return on Equity is forecast to be low in 3 years time (13.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y